4KNB

C-Met in complex with OSI ligand


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.40 Å
  • R-Value Free: 0.288 
  • R-Value Work: 0.240 
  • R-Value Observed: 0.241 

wwPDB Validation 3D Report Full Report



Literature

Novel 6-aminofuro[3,2-c]pyridines as potent, orally efficacious inhibitors of cMET and RON kinases.

Steinig, A.G.Li, A.H.Wang, J.Chen, X.Dong, H.Ferraro, C.Jin, M.Kadalbajoo, M.Kleinberg, A.Stolz, K.M.Tavares-Greco, P.A.Wang, T.Albertella, M.R.Peng, Y.Crew, L.Kahler, J.Kan, J.Schulz, R.Cooke, A.Bittner, M.Turton, R.W.Franklin, M.Gokhale, P.Landfair, D.Mantis, C.Workman, J.Wild, R.Pachter, J.Epstein, D.Mulvihill, M.J.

(2013) Bioorg Med Chem Lett 23: 4381-4387

  • DOI: 10.1016/j.bmcl.2013.05.074
  • Primary Citation of Related Structures:  
    4KNB

  • PubMed Abstract: 
  • A series of novel 6-aminofuro[3,2-c]pyridines as kinase inhibitors is described, most notably, OSI-296 (6). We discuss our exploration of structure-activity relationships and optimization leading to OSI-296 and disclose its pharmacological activity a ...

    A series of novel 6-aminofuro[3,2-c]pyridines as kinase inhibitors is described, most notably, OSI-296 (6). We discuss our exploration of structure-activity relationships and optimization leading to OSI-296 and disclose its pharmacological activity against cMET and RON in cellular assays. OSI-296 is a potent and selective inhibitor of cMET and RON kinases that shows in vivo efficacy in tumor xenografts models upon oral dosing and is well tolerated.


    Organizational Affiliation

    OSI Pharmaceuticals, LLC, A Wholly-Owned Subsidiary of Astellas US, 1 Bioscience Park Drive, Farmingdale, NY 11735, USA. arnosteinig@gmail.com



Macromolecules
Find similar proteins by:  (by identity cutoff)  |  Structure
Entity ID: 1
MoleculeChainsSequence LengthOrganismDetailsImage
Hepatocyte growth factor receptorABCD287Homo sapiensMutation(s): 0 
Gene Names: MET
EC: 2.7.10.1
Find proteins for P08581 (Homo sapiens)
Explore P08581 
Go to UniProtKB:  P08581
NIH Common Fund Data Resources
PHAROS  P08581
Protein Feature View
Expand
 ( Mouse scroll to zoom / Hold left click to move )
  • Reference Sequence
Small Molecules
Ligands 2 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
1RU
Query on 1RU

Download CCD File 
A, B, C, D
7-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-3-[1-(piperidin-4-yl)-1H-pyrazol-4-yl]furo[3,2-c]pyridin-6-amine
C23 H22 Cl2 F N5 O2
RFKWZWJQRQCLJF-GFCCVEGCSA-N
 Ligand Interaction
GBL
Query on GBL

Download CCD File 
A, B
GAMMA-BUTYROLACTONE
C4 H6 O2
YEJRWHAVMIAJKC-UHFFFAOYSA-N
 Ligand Interaction
External Ligand Annotations 
IDBinding Affinity (Sequence Identity %)
1RUIC50:  47   nM  BindingDB
1RUIC50:  410   nM  BindingDB
1RUIC50:  47   nM  Binding MOAD
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.40 Å
  • R-Value Free: 0.288 
  • R-Value Work: 0.240 
  • R-Value Observed: 0.241 
  • Space Group: P 1 21 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 44.713α = 90
b = 85.922β = 91.47
c = 156.469γ = 90
Software Package:
Software NamePurpose
REFMACrefinement
XDSdata reduction
XSCALEdata scaling

Structure Validation

View Full Validation Report



Entry History 

Deposition Data

Revision History 

  • Version 1.0: 2014-04-30
    Type: Initial release